INTRODUCTION
Mycobacterium tuberculosis is a member of the bacterial Mycobacteriaceae family and is known to cause tuberculosis (TB) in humans. The World Health Organization (WHO) reported the death of 1.7 million M. tuberculosis-infected persons in 2016 and estimated 10.4 million new cases of tuberculosis patients per year worldwide.
1,2 Emergence of multidrug-resistant strains makes the situation more ominous. 1 Therefore, to develop alternative treatments against both drugsusceptible and multidrug-resistant strains, discovery of novel and highly conserved drug targets is warranted. G-quadruplex-forming nucleic acid motifs are one of the most studied evolutionarily conserved drug targets and are copiously found in critical regions of genomes of various organisms ranging from eukaryotes to prokaryotes and viruses. 3, 4 In humans, G-quadruplexes have been found to be associated with the regulation of vital cellular processes such as replication, recombination, transcription, and translation. 5 In addition to the telomere, G-quadruplexes have also been identified in the promoter regions of various proto-oncogenes, such as KRAS, Bcl-2, c-Kit, PDGF-A, c-MYC, VEGF, and c-Myb, and are considered as potential therapeutic targets for cancer treatment. [6] [7] [8] [9] [10] Recently, various viruses such as HIV, Ebola virus, hepatitis B virus (HBV), herpes simplex virus (HSV), human papillomavirus (HPV), hepatitis C virus (HCV), severe acute respiratory syndrome (SARS) coronavirus, Zika virus, and Epstein-Barr virus (EBV) were also reported to harbor conserved G-quadruplex structures in the coding region of various structural and non-structural proteins. 11 In all these cases, G-quadruplexes either play a regulatory role in replication, transcription, and packaging of the viral genome or help the viruses in immune evasion. 11 Among the vast kingdom of prokaryotes, only a few pathogenic bacteria have been explored for the presence of G-quadruplex sequences in their genome such as Neisseria gonorrhoeae and Deinococcus radiodurans.
12,13 Conserved G-quadruplexes are shown to be responsible for antigenic variations in Neisseria gonorrhoeae 14 and Treponema pallidium. 15 Previously, several strain-specific G-quadruplexes were also reported in the genome of Mycobacterium tuberculosis (H37Rv strain). 16, 17 Therefore, here in the present study, we sought to explore novel and highly conserved putative G-quadruplex-forming sequences in all 160 available and completely sequenced strains of M. tuberculosis. Bioinformatics analysis revealed the presence of highly conserved potential G-quadruplex motifs (PGQs) in three essential genes of M. tuberculosis, namely, espK, espB, and cyp51 that were responsible for the virulence of bacteria inside the host cell. Insights into pathogenic mechanisms of M. tuberculosis infection indicate that it is a facultative intracellular human pathogen and survives in the host environment by preventing the maturation of phagosomes into phagolysosomes. 18, 19 Previously, the M. tuberculosis genome has been revealed to possess an extended region of difference 1 (extRD1) locus that harbors genes for early secretory antigenic target 6 (ESAT-6) system 1 (ESX-1) secretion machinery, a type VII secretion system (T7SS). 20 This T7SS utilizes EspK (encoded by Rv3879) for secreting ESAT-6 and culture filtrate protein 10 (CFP-10) as a dimer ( Figure S1A ). After secretion, the ESAT-6 and CFP-10 dimer complex enters into the endoplasmic reticulum (ER) of macrophages and sequesters Beta-2-Microglobulin (b2M) protein, an essential component of MHC class I system. 21 This sequestration reduces MHC class I-mediated antigen presentation, an innate immune response of the host cell. 21 In addition to ESAT-6 and CFP-10, ESX-1 also secretes another ESX-substrate protein, EspB. EspB interacts with the C-terminal region of EspK protein and directly portrays an inhibitory role in the maturation of phagosome. 18, 20 Upon EspKassisted secretion of EspB outside the cytosol by ESX-1 secretion machinery ( Figure S1A ), EspB undergoes oligomerization, binds to phospholipids of host macrophages, and initiates a membranolytic or pore-forming phenomenon inside the phagosome that serves as a crucial initial step of immune evasion for bacteria. 22 Thus, secretion of EspB helps the bacteria in suppressing the innate immune response of the host cell and promotes its survival within the host 20 (Figure S1A ). Above insights into ESX-1 secretion machinery revealed the crucial role of EspB and EspK proteins in the pathogenesis of M. tuberculosis within the host and suggested that inhibition of espK and espB expression could lead to a synergistic reduction in M. tuberculosis virulence and pathogenesis, and thus represents a novel therapeutic approach. The cyp51 gene is another PGQ-possessing gene that has been previously reported to be involved in sterol biosynthesis pathway and membrane formation. [23] [24] [25] [26] Because our bioinformatics analysis revealed the PGQs in the espk, espB, and cyp51 genes, in the present work, we sought to investigate the regulatory role of these PGQs on the expression of PGQ-possessing genes.
To accomplish this, we used various biophysical and biochemical techniques, and confirmed the formation of G-quadruplex structures by predicted PGQs. Isothermal titration calorimetry (ITC) and circular dichroism (CD) melting analysis allowed us to demonstrate the affinity of TMPyP4 to PGQs. Next, polymerase stop assay and qRT-PCR assay of RNA from a M. tuberculosis culture treated with TMPyP4 confirmed the downregulation of all PGQs possessing genes espK, espB, and cyp51. Therefore, this study demonstrates a novel approach for developing active therapeutics against M. tuberculosis infection by exploiting PGQ targets ( Figure S1B ).
RESULTS
Putative G-Quadruplex Sequences in the M. tuberculosis Genome and Their Evolutionary Conservation Currently, there are very few effective drugs available for the treatment of the M. tuberculosis infection, and the emergence of extremely drug-resistant strains and latent infections ring a global alarm for investigating novel conserved drug targets and drug regimens. 27, 28 Depending on nucleotide base composition, nucleic acids can adopt several distinct secondary structures such as duplex, triplex, hairpin, and quadruplex structures. 29 Among these secondary structures, the G-quadruplex structure has been represented as the most studied evolutionarily conserved drug target, and several small molecules have been developed that modulate (stabilize or destabilize) these G-quadruplex structures and have potential to be used as a promising drug target in the battle against human pathogens.
Considering the suitability of G-quadruplexes as an evolutionarily conserved promising drug target, we searched the genomic sequences of all available strains of M. tuberculosis in the NCBI database for the presence of PTQs (MTB-PGQs) by employing a G-quadruplex (G4) prediction algorithm previously developed by our group. All predictions were then confirmed by tools developed by other groups (Tables S1, S2 , S3, S4, S5, S6, S7, S8, S9, and S10). [30] [31] [32] Because G4 structure folding relies on different patterns and length of consecutive G-tracts and loops ( Figure S2 ), we set the constraint of 3 or 4 nt www.moleculartherapy.org as the minimum length of G-tract, and 0 and 20 nt as the least and highest length of loops, respectively. The G4 prediction algorithm with the above set of parameters was employed on the 160 completely sequenced M. tuberculosis strains (Table S7) , allowing us to identify more than 4,000 potential G4-forming sequences (Tables S1 and S2 ). Considering that the likeness between two sequences may associate with similar functions, we further sought to correlate the sequence similarity between each of the MTBPGQs and their function. The unweighted pair group method with arithmetic mean (UPGMA) clustering method was utilized to measure the similarity between a large set of MTB-PGQs that defines the likeness hierarchy between the given set of strings. 33 This clustering analysis clusters PGQs that have almost identical sequences, similar function, and are susceptible to form G4s with the same topology (Tables S3 and S4 ). For combating multidrug-resistant bacterial infection, evolutionary conservation is a requisite that satisfies one of the criteria to work as a promising drug target. Therefore, we employed the BLAST algorithm to calculate the occurrence of each cluster in all 160 available strains of M. tuberculosis. To demonstrate the conservation of these clusters, we have employed the following equation: p = (n O N) Â 100, where p is the frequency of occurrence, n is the total number of strains in which a particular PGQ is present, and N is the total number of M. tuberculosis strains. Table S8 demonstrated the details of the MTB-PGQs occurring with >98% frequency and present in the essential genes of the 160 strains of M. tuberculosis. For further analysis, we have chosen 100% conserved MTB-PGQs because of their presence in the genome of both drug-susceptible and drug-resistant strains of bacteria. The clustering analysis followed by the conservation mapping revealed three MTB-PGQs as 100% conserved in M. tuberculosis (Table S9 ) and present in three essential genes of the bacteria, namely, espK (MTB-PGQ1), espB (MTB-PGQ2), and cyp51 (MTB-PGQ3). Figure S4 ).
Evaluation of the Formation of G4 Structures and Their Stability by Employing Circular Dichroism Spectra and Melting Analysis
Circular dichroism is among the most dependable methods to portray the formation of G4 structures by DNA oligonucleotides. Previous studies have observed that: (1) a positive peak at $265 nm and a negative peak at $240 nm correspond to a parallel G4, whereas (2) a positive peak at 290 nm and a negative peak at 260 nm indicate antiparallel G4 formation, and (3) two positive peaks at 260 and 290 nm coupled with a negative peak at 240 nm represent a mixed or hybrid G4 structure. 34 Different cations exert variable effects on the stability and folding pattern of G4 structures. The ranking of stabilizing ability among the well-studied cations is as follows: K + > Na + > Mg 2+ > Li + . 35 Therefore, we assessed the topology of conserved MTB-PGQs using CD spectra and CD melting curve analysis in four different buffers containing related cations K + , Na + , Mg + , and Li + . CD spectra analysis revealed a predominantly parallel G4 topology exhibited by all conserved MTB-PGQs. As expected, the molar ellipticity and melting temperature of each MTB-PGQ were found to be higher in the presence of K + ions (Figure 2 ). CD spectra analysis performed in the presence of an increasing concentration of K + ions revealed an increase in molar ellipticity as a function of K + ion concentration ( Figure S5 ).
We then mutated the central guanine nucleotide of all of the G stretches into thymine and evaluated the G4-forming ability of mutated MTB-PGQs (mut-MTB-PGQs) in K + buffer (Table S10 ).
All of the mutants (mut-MTB-PGQ1, mut-MTB-PGQ2, and mut-MTB-PGQ3) did not show CD signals that correspond to G4 topology and suggested the disruption of the G4 structure formation by the guanine mutation (Figure 2 ).
Electrophoretic Mobility Shift Assay Indicated the Formation of the Intramolecular G4 by MTB-PGQs
Further, we performed an electrophoretic gel mobility shift assay (EMSA) to check the presence of multimeric structures and determined the molecularity of these assemblies in solution. In the case of G4 folding, a fast-moving oligonucleotide band is considered to correspond to an intramolecular topology, whereas a slow-moving oligonucleotide band is likely to correspond to an intermolecular structure. [36] [37] [38] We examined the rate of migration for all MTBPGQs oligos, as well as mutant sequences on native PAGE. All of the MTB-PGQ oligonucleotides migrate at a faster rate as compared with their mutant sequences, suggesting the formation of intramolecular complexes by all PGQs ( Figure S6 ).
Exploration of G4 Structure Formation by NMR
NMR spectroscopy is a highly reliable technique to confirm the formation of stable G4 structures by nucleic acids. 
Stabilizing and Energetically Favorable Interaction of the PGQs with the Representative G4 Ligand
Various G4 binding ligands have been investigated for their therapeutic potential by affecting the stability of the G4 structure, such as TMPyP4, BRACO-19, etc. 11, 41, 42 TMPyP4 acts as an anti-cancer agent by stabilizing G4 structures present at human telomeres. 43 It also inhibits viral RNA processing inside host cells by stabilizing the G4 structure present in the L gene of the Ebola virus and acts as an anti-Ebola virus (EBOV) agent. 11, 41 Recently, BRACO-19 was shown to inhibit M. tuberculosis growth, but its cellular target remains to be identified. 17 In our study, we assessed the stabilizing activity of TMPyP4 for MTBPGQs by CD melting curve analysis. Melting curves of MTB-PGQs in the absence and presence of TMPyP4 yielded an increase in melting temperature (T m ) of $8 C, indicative of a stabilizing effect of TMPyP4 on the thermostability of G4 structures formed by MTB-PGQs ( Figure 4A ). Further, we assessed the binding affinity of TMPyP4 for the G4 forming MTB-PGQ oligos by ITC. Changes in enthalpy (DH 1 ) associated with binding to MTB-PGQ1, MTB-PGQ-2, and MTB-PGQ3 were very negative, indicative of an energetically favorable binding of TMPyP4 to MTB-PGQs. 44 The association constants (K A ) for the high-affinity site of MTB-PGQ1, MTB-PGQ2, and MTB-PGQ3 were 1.33 Â 10 6 M À1 , 2.58 Â 10 6 M À1 , and 2.05 Â 10 6 M À1 , respectively. These results confirm a thermodynamically stable interaction between TMPyP4 and MTBPGQs with affinities in the micromolar range ( Figure 4B ). We also took a non-G4-forming sequence as a negative control to observe selectivity of TMPyP4 for the G4 structure. ITC results indicate 33-, 64-, and 50-fold tighter binding of TMPyP4 to MTB-PGQ1, MTB-PGQ2, and MTB-PGQ3, respectively, than to the non-quadruplexforming sequence.
Effect of TMPyP4 on M. tuberculosis Growth NMR, CD, and EMSA experiments indicated the formation of G4 structures by conserved MTB-PGQ. Moreover, ITC and CD melting analysis revealed energetically favorable high affinity of TMPyP4 for the conserved MTB-PGQs. Therefore, we further addressed the effect of TMPyP4 on M. tuberculosis survival using an inhibition assay ( Figure 5 ). The observed IC 50 value was 6.25 mM, a value lower than the IC 50 values of the TMPyP4 for both malignant and normal eukaryotic cells.
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TMPyP4 Stalls the Replication Machinery at G4 Sites
Next, we sought to investigate whether TMPyP4 binding to the PGQ motif inhibits DNA replication or not. To accomplish this, we employed two variants of stop assay: (1) PCR stop assay and (2) Taq DNA polymerase stop assay. 46 In PCR stop assay, a G-region overlapping primer was utilized for PCR amplification. In the absence of TMPyP4, a double-stranded product formed because of the primer annealing and extension. 46 The presence of TMPyP4 leads to the stabilization of G4 in the template that results in the unavailability of the template for primer annealing, and thus PCR got inhibited (fully inhibited at higher concentration and partially inhibited at a lower concentration). As shown in Figure S7 , increasing concentrations of TMPyP4 have a strong impact on PCR amplification. On the contrary, when mut-MTB-PGQs were used as a DNA template, TMPyP4 did not inhibit DNA synthesis leading to full product generation.
However, the Taq polymerase stop assay assesses the ability of TMPyP4 to stabilize the G4 structure and stop the movement of polymerase enzyme during PCR extension reaction at MTB-PGQ sites. 46 Figure S8 depicts the results of Taq polymerase stop assay for the three templates and negative control. In the absence of TMPyP4, full-length product is formed but with increasing concentrations of TMPyP4, the shorter band was observed with the decreasing band intensity, whereas neither smaller product nor diminishing bands intensities were observed in the negative control.
Next, we sought to examine the effect of TMPyP4 on transcription of the G4 motif-possessing genes espK, espB, and cyp51
by qRT-PCR. The transcripts of genes were quantified relative to the transcript of 16S rRNA gene (a housekeeping gene), and quantification cycle (Cq) of non-template controls was >35 cycles. As shown in Figure 6 , treatment of the M. tuberculosis cells with 6.25 mM TMPyP4 reduced the transcription of the espK, espB, and cyp51 genes by 3.70-, 1.91-, and 6.25-fold, respectively, relative to the untreated culture control. These results strengthen the likelihood of a role for a G4-mediated mechanism in the transcription of the G4 motif-containing genes espK, espB, and cyp51, and open a novel therapeutic avenue for combating this deadly human pathogen.
Recently, G4s were recognized as highly conserved and promising drug targets for combating the infection of various polymorphic and lethal human pathogens. 11, 47 For example, the presence of the G4 motif in the pre-S2/S gene promoter upregulates the activity of HBV inside human cells. 48 Recently, G4 motifs in the genes of the various structural proteins of the Zika virus were found to be promising drug targets. 49 Similarly, in the case of the Kaposi's sarcoma-associated herpesvirus (KSHV), a G4 motif was found to lie in between the kaposin (DR6) and oriLyt-R, oriLyt-L and K5 9, and v-IRF2 and v-IRF3 genes, and was observed to regulate the replication and transcription of the viral genome inside the host cell. 50 In HIV, a G4 found at unique long terminal repeat (LTR) promoter regions has been proposed as a potent target for anti-HIV therapy. 51 The pac1 signal required for successful cleavage and packaging of the Human Herpesvirus, and the presence of the G4 motif in this region suggested their novel function in the viral genome. 52 Altogether, bioinformatics analysis, 1D 1 H NMR, CD spectroscopy, and EMSA revealed the presence of 100% conserved intramolecular parallel G4-forming motifs in three essential bacterial genes, namely, espK (Rv3879c), espB (Rv3881c), and cyp51 (Rv0764c). Similar to the G4 target in the above-mentioned human pathogen, a G4 motif present in these genes may also serve as a potential target for developing an anti-bacterial therapy. These G-rich targets can also overcome the problem of the drug resistance because of their 100% conservation in both drug-susceptible and drug-resistant bacterial strains (including extremely drug-resistant strains).
Because these G4s are present in the coding regions of the espK, espB, and cyp51 genes, we probed the presence of GQs and the consequence of stabilizing these motifs using TMPyP4, a wellknown G4 stabilizing ligand. First, the observed increase in T m by >8
C in the presence of TMPyP4 established the presence of PGQ sequences in these genes. Second, the presence of PGQ sequences was confirmed by the observed stalling of DNA replication in the presence of TMPyP4 in a PCR stop assay. The binding interaction between TMPyP4 and MTB-PGQs was determined by ITC analysis to be thermodynamically stable, energetically favorable, and selective. Finally, we evaluated the inhibitory effect of TMPyP4 on M. tuberculosis growth; IC 50 value was calculated to be 6.25 mM. Highly stable G4s in the open reading frame of genes were previously shown to downregulate the expression of genes. 13, 41, 53 The treatment of M. tuberculosis cultures with TMPyP4 led to a significant decrease in the expression of espK and espB relative to 16S rRNA, a housekeeping gene, suggesting that a G4-mediated inhibition mechanism is involved in this process. As a schematic model elaborated in Figure S1B , G4-mediated inhibition of espK and espB genes is expected to increase the innate immune response of host cell. The inhibited expression of the espB and espK proteins would restore the phagosome maturation process and reduce the secretion of CFP-10 and ESAT-6, in turn leading to a rescued antigen presentation to the host immune cells.
In conclusion, the current study has identified and confirmed the presence of highly conserved G4 motifs in virulence determining genes of M. tuberculosis. Moreover, the presence of these PGQs in other Mycobacterium species suggests their conserved role in the survival and virulence of bacteria, and allows us to propose them as a suitable therapeutic target for inhibiting the bacterial pathogenicity. The presence of GQs was confirmed using various biophysical approaches in the presence of a G4 stabilizing agent, TMPyP4. Lastly, the inhibitory role of GQs in the expression of espK and espB virulence genes and in the survival of M. tuberculosis was demonstrated. TMPyP4 can inhibit intracellular transcription of the G4-containing genes. Taking together all the results, this study demonstrates that the G4s in the espK and espB genes can be considered as novel targets for the development of anti-tuberculosis compounds.
MATERIALS AND METHODS
Please see the Supplemental Information for the detailed explanation of all experimental procedures and materials used in this study.
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